The Benefits Of Conducting A Clinical Trial In Canada

Tune in to this informative webinar where the following Altasciences' regulatory experts delve into the intricacies of Health Canada's Clinical Trial Application (CTA) regulatory submission process, addressing some of the industry's most pressing queries:

• Chad Rathlef, Senior Director, Business Development, Altasciences
• Roland Jbeily, MSc, D.E.S.S., Manager, Regulatory Affairs, Altasciences
• Yewande Obadipe, Specialist, Regulatory Affairs, Altasciences

During this webinar, viewers will gain valuable insights into the intricacies of navigating Health Canada's regulatory landscape, ensuring that clinical trials run smoothly and efficiently. In addition, the featured speakers will also provide practical solutions to common challenges encountered during the CTA submission process. Whether you're a seasoned researcher or new to the field, this webinar is a valuable resource for enhancing your understanding of clinical trial regulations in Canada and optimizing your research endeavors.

Altasciences boasts a robust clinical facility in Canada, comprising seven state-of-the-art Phase 1 units. Its extensive experience includes overseeing more than 100 clinical trials annually, covering a diverse spectrum of research, including first-in-human studies, specialized investigations, and various therapeutic domains such as ophthalmology, central nervous system (CNS) research, and substance abuse studies.